First-In-Human Trial Of Bcma-Cd19 Compound Car With Remarkable Donor-Specific Antibody Reduction

Fang Liu,Hongyu Zhang, Xiao Wang,Yisong Xiong,Yuanzhen Cao,Yi Su,Hai Yi,Jia Feng,Wenli Zhang,Yu Ma,Masayuki Wada,Yupo Ma

BLOOD（2019）

引用 4|浏览31

暂无评分

摘要

Ma: iCAR Bio Therapeutics Ltd: Employment. Wada:iCell Gene Therapeutics LLC: Employment. Ma:iCell Gene Therapeutics LLC: Consultancy, Equity Ownership, Research Funding; iCAR Bio Therapeutics Ltd: Consultancy, Equity Ownership, Research Funding.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要